How can we increase translation of research into practice? Types of evidence needed

被引:701
作者
Glasgow, Russell E. [1 ]
Emmons, Karen M.
机构
[1] Kaiser Permanente, Denver, CO 80231 USA
[2] Dana Farber Canc Inst, Boston, MA 02115 USA
[3] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA
关键词
research methods; public health impact; validity; dissemination;
D O I
10.1146/annurev.publhealth.28.021406.144145
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
This review summarizes key factors that have interfered with translation of research to practice and what public health researchers can do to hasten such transfer, focusing on characteristics of interventions, target settings, and research designs. The need to address context and to utilize research, review, and reporting practices that address external validity issues-such as designs that focus on replication, and practical clinical and behavioral trials-are emphasized. Although there has been increased emphasis on social-ecological interventions that go beyond the individual level, interventions often address each component as if it were an independent intervention. Greater attention is needed to connectedness across program levels and components. Finally, examples are provided of evaluation models and current programs that can help accelerate translation of research to practice and policy.
引用
收藏
页码:413 / 433
页数:23
相关论文
共 102 条
[1]   PATIENT EMPOWERMENT - RESULTS OF A RANDOMIZED CONTROLLED TRIAL [J].
ANDERSON, RM ;
FUNNELL, MM ;
BUTLER, PM ;
ARNOLD, MS ;
FITZGERALD, JT ;
FESTE, CC .
DIABETES CARE, 1995, 18 (07) :943-949
[2]  
[Anonymous], EXPT QUASI EXPT DESI
[3]  
[Anonymous], EFFECTIVE CLIN PRACT
[4]  
[Anonymous], 2002, Process evaluation for public health interventions and research
[5]   IMPROVING DRUG-THERAPY DECISIONS THROUGH EDUCATIONAL OUTREACH - A RANDOMIZED CONTROLLED TRIAL OF ACADEMICALLY BASED DETAILING [J].
AVORN, J ;
SOUMERAI, SB .
NEW ENGLAND JOURNAL OF MEDICINE, 1983, 308 (24) :1457-1463
[6]   A RANDOMIZED TRIAL OF A PROGRAM TO REDUCE THE USE OF PSYCHOACTIVE-DRUGS IN NURSING-HOMES [J].
AVORN, J ;
SOUMERAI, SB ;
EVERITT, DE ;
ROSSDEGNAN, D ;
BEERS, MH ;
SHERMAN, D ;
SALEMSCHATZ, SR ;
FIELDS, D .
NEW ENGLAND JOURNAL OF MEDICINE, 1992, 327 (03) :168-173
[7]   AVOIDING TYPE-III ERRORS IN HEALTH-EDUCATION PROGRAM EVALUATIONS - A CASE-STUDY [J].
BASCH, CE ;
SLIEPCEVICH, EM ;
GOLD, RS ;
DUNCAN, DF ;
KOLBE, LJ .
HEALTH EDUCATION QUARTERLY, 1985, 12 (04) :315-331
[8]   A randomized trial of group outpatient visits for chronically ill older HMO members: The cooperative health care clinic [J].
Beck, A ;
Scott, J ;
Williams, P ;
Robertson, B ;
Jackson, D ;
Gade, G ;
Cowan, P .
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 1997, 45 (05) :543-549
[9]   PSYCHOACTIVE MEDICATION USE IN INTERMEDIATE-CARE FACILITY RESIDENTS [J].
BEERS, M ;
AVORN, J ;
SOUMERAI, SB ;
EVERITT, DE ;
SHERMAN, DS ;
SALEM, S .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1988, 260 (20) :3016-3020
[10]   Disseminating innovations in health care [J].
Berwick, DM .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 289 (15) :1969-1975